NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Caplight Logo









Shenzhen Sangel Venture Capital

Shenzhen Sangel Venture Capital

Shenzhen, Guangdongsangelvc.com

Overview

Sangel Capital is one of the earliest established healthcare venture capital firms in China. Dedicated to novel technologies and healthcare innovation, the firm focuses on investing in startups in biotech, biopharma, medical devices, and digital health . Sangel Capital provides venture capital and business finance to support high-tech enterprises in China and Western countries .

Year Founded

2009

Portfolio Companies

9

Investments

CompanyDateStageLead
BriSTAR ImmunotechOct 2021Series BCo-investor
PersonGen BioTherapeuticsMay 2021Series ACo-investor
PredicineJul 2020Series BCo-investor
Quantapore, Inc.Jul 2018Series 3Co-investor
PredicineApr 2018Series ALead
View all investments

Sector & Stage Mix

Industry, funding stage, and valuation band breakdowns.

Premium
SeedSeries ASeries BGrowth

Unlock portfolio analytics

Sign up to view full sector, stage, and valuation breakdowns for this investor.

Investment Activity

Yearly cadence, pace, and funding raised over time.

Premium
2021
2022
2023
2024
2025
2026

Unlock portfolio analytics

Sign up to explore yearly investment trends and funding raised over time.

FAQ

Firmographic Details

HeadquartersShenzhen, Guangdong
Year Founded2009

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.





Caplight Logo




ProductsSecondary Data & TradingCaplight MarketPrice™Company DatabaseInvestor DatabaseSourcingAPI & MCP

Use CasesInvestorsEmployees

ResourcesResearch & BlogAboutCareers

LegalPrivacy PolicyTerms of UseBrokerCheckForm CRS


Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.